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Collagen V, a ﬁbrillar collagen with important functions in tissues, assembles into distinct chain associations. The most abundant
and ubiquitous molecular form is the heterotrimer [α1(V)]2α2(V). In the attempt to produce high levels of recombinant collagen
V heterotrimer for biomedical device uses, and to identify key factors that drive heterotrimeric chain association, several cell
expression systems (yeast, insect, and mammalian cells) have been assayed by cotransfecting the human proα1(V) and proα2(V)
chain cDNAs. Suprisingly, in all recombinant expression systems, the formation of [α1(V)]3 homotrimers was considerably
favored over the heterotrimer. In addition, pepsin-sensitive proα2(V) chains were found in HEK-293 cell media indicating that
these cells lack quality control proteins preventing collagen monomer secretion. Additional transfection with Hsp47 cDNA,
encoding the collagen-speciﬁc chaperone Hsp47, did not increase heterotrimer production. Double immunoﬂuorescence with
antibodies against collagen V α-chains showed that, contrary to ﬁbroblasts, collagen V α-chains did not colocalized intracellularly
in transfected cells. Monensin treatment had no eﬀect on the heterotrimer production. The heterotrimer production seems to
require speciﬁc machinery proteins, which are not endogenously expressed in the expression systems. The diﬀerent constructs and
transfected cells we have generated represent useful tools to further investigate the mechanisms of collagen trimer assembly.
1.Introduction
The extracellular matrix (ECM) consists for the most part of
collagen proteins that form ﬁbrils and other supramolecular
structures from triple-helical collagen molecules. Collagen
V is a quantitatively minor ﬁbrillar collagen with a broad
distribution in tissues such as dermis, tendons, bones,
blood vessels, and cornea. Among the diﬀerent members
of the ﬁbrillar collagens, collagen V has the particularity to
assemble into diﬀerent chain associations that can include
hybrid molecules containing collagen XI chains [1, 2].
The most abundant and ubiquitous molecular form is
the heterotrimer [α1(V)]2α2(V), which copolymerizes with
collagen I to form heterotypic ﬁbrils in tissues. The het-
erotrimers α1(V)α2(V)α3(V) and the homotrimer [α1(V)]3
represent minor isoforms that show a more restricted
expression pattern [1, 3]. The physiological relevance of
these three molecular minor forms is unclear. A wealth of
evidence favours the role of the heterotrimer [α1(V)]2α2(V)
in the control [4] and nucleation of ﬁbril assembly [2,2 Journal of Biomedicine and Biotechnology
5], a function that is not shared with the homotrimer
[α1(V)]3 [6]. Many studies point to a role of collagen V
heterotrimer in the control of collagen ﬁbril diameter in
cornea. Corneal injuries often result in cloudy or opaciﬁed
scars which appears to develop from disruption of the
organized collagen matrix and that require transplantation
of donated or artiﬁcial corneas. The construction of a
scaﬀold made of heterotypic collagen I/V collagen ﬁbrils
as in native stroma, would be an important asset in the
development of bioengineered corneal implants. Recently,
Torbet and coworkers [7] have reported that a stroma-like
scaﬀold consisting of a stack of orthogonally disposed sheets
of aligned collagen I ﬁbrils can be built up using magnetic
alignment. The recombinant technology represents a valu-
able alternative for collagen production to be used for tissue
engineering.
S e v e r a la t t e m p t sh a v eb e e nm a d et oe x p r e s sc o l l a g e n s
in diﬀerent recombinant systems. Although recombinant
expression of collagens was initially considered as a dif-
ﬁcult task, these large, multimeric, and modular proteins
have been successfully expressed in most of the existing
expression systems. But the use of recombinant collagens
has often been limited to their biochemical characterization
in fundamental research because of the production yield
that is so far not adapted to tissue engineering needs (for
review see [8]). Another diﬃculty is the achievement of
collagen heterotrimeric assembly in heterologous expression
systems. Whereas the recombinant production of colla-
gen homotrimeric molecular forms has been achieved in
diﬀerent expression systems, the production of collagen
heterotrimers is still challenging.
Recombinant protein expression systems include a wide
varietyoforganismsfrombacteriatomammaliancells.How-
ever, production of recombinant collagen proteins presents
various problems in part because the numerous posttrans-
lational modiﬁcations required to achieve a correctly folded
multimeric conformation are often crucial to preserve their
functions. The choice of the expression cell system is there-
fore of fundamental importance to obtain a recombinant
molecule in conformity with the natural protein to maintain
itsfunction(forareview,see[8]).Oneofthemainstructural
properties of collagens is the thermostability of the triple
helix domain, which is dependent on the hydroxylation of
the proline residues in the Y-position of the collagenous
Gly-X-Y triplet. The speciﬁc enzyme involved is prolyl 4-
hydroxylase which is not present in prokaryotes and lower
eukaryotes. Prokaryotic expression systems provide cheap
maintenance and easy up-scaling properties of heterologous
protein production. Human collagens have proved diﬃcult
to express in bacteria due to the triple helix folding and
thermostability requirement. High-level expression of active
human prolyl 4-hydroxylase (P4H) in E.coli has been the
bottleneck until recently [9].
Yeast such as Pichia pastoris and Saccharomyces cerevisiae
are frequently used as an expression system for the produc-
tion of proteins. The advantages of yeast cells over bacteria
are high-density fermentation, processing machinery similar
to higher eukaryotes, and secretion to the culture media.
Moreover, once the recombinant gene is in the genome of
the yeast cell, a stable expression is achieved (for a review, see
[10]). Thermostable ﬁbrillar collagens I, II, and III have been
successfully expressed after the lack of prolyl 4-hydroxylase
was solved by stable transformation of Pichia pastoris with
enzyme subunits [11–14].
Rod shaped baculoviruses capable of infecting only cer-
tain insects are eﬃcient and safe expression vectors for large-
scale production of recombinant proteins. Moreover, the
recombinant proteins expressed in the baculovirus expres-
sion system are usually properly folded, disulﬁde-bonded,
and localized to the correct subcellular compartment. Even
though insect cells are higher eukaryotes than yeast cells,
they do not have prolyl-4-hydroxylase activity. By expressing
prolyl 4-hydroxylase subunits with collagens I, II, and III α-
chains in insect cells, it was possible to achieve thermostable
collagen I, II, and III trimeric molecules [15–18].
The advantages of mammalian expression systems
include full range posttranslational modiﬁcations and secre-
tion of the heterologous protein in the culture media. The
HEK HEK-293 is the most commonly used cell line forlarge-
scale matrix protein expression. Collagens recombinantly
producedinHEK-293cellsaregenerallyfullyhydroxylatedas
we showed for the ﬁrst time for collagen V homotrimer [19]
and further proven to be true for other homotrimeric colla-
gens[8].ProductionofrecombinantcollagenVheterotrimer
has already been reported in the HEK-293 cell line. However,
when 15–20μg/ml of homotrimer collagen V was produced
in these cells [6, 19], only negligible amount of 0.8μg/ml of
heterotrimeric collagen V was obtained by cotransfecting the
proα1(V) and proα2(V) chains [20].
In this paper, the three diﬀerent eukaryotic expression
systems have been used to monitor the expression of recom-
binant human collagen V heterotrimer, the most prevalent
in vivo molecular form of collagen V: yeast, baculovirus-
insect cell, and mammalian cell expression systems, in
order to deﬁne the most suitable expression system to
get substantial amounts of collagen V heterotrimer for
biomedical device uses and to identify important factors that
drive heterotrimeric chain association.
2.MaterialsandMethods
2.1. Preparation of Constructs. Human proα1(V) (Gene
bank accession number P20908) and proα2(V) (Gene bank
accession number P05997) cDNA sequences were used for
this study.
2.1.1. Baculovirus Transfer Vectors. A pBlueScript KS clone,
in which a NaeI-PstI digested fragment of proα1(V) cDNA
(pBS51nae, a gift from D. Greenspan) was cloned, had an
extra ATG nucleotide sequence near the original initiation
codon in the 5  UTR, and it was removed by site directed
mutagenesis. A PCR primer containing a HindIII restriction
s i t ea n da nAt oTm u t a t i o nw a sd e s i g n e d( 5  -CGA-
TAAGCTTGTTGGCATGGACTGC-3 ) and used to multi-
ply a 912 nt fragment of proα1(V) cDNA together with a
primer 5 AGCTTCCACGGGCTTCTTGCTG3  correspond-
ing to the nucleotides downstream of an AvrII restriction siteJournal of Biomedicine and Biotechnology 3
in exon 6 of proα1 (V)c D N A .Th eP C Rp r od u ct sw e r el i ga t ed
in pGEM-T easy-vector (Promega). The inserted cDNA was
digestedwithHindIII-AvrIIandligatedtopBS51naedigested
withHindIII-AvrII. The whole proα1(V) cDNA was digested
out from pBS51nae with HindIII-NotI, the protruding ends
were ﬁlled using Taq polymerase and the cDNA was ligated
to pGEM-T easy-vector. The resulting pGEMTe-C5A1 was
digested with NotI-SpeI and the proα1(V) cDNA was ligated
to pVL1392 digested with NotI-XbaI (pVLC5A1).
A XbaI restriction site was created six nucleotides
upstream of the translation initiation codon to a full length
proα2(V) cDNA (a gift from D. Greenspan) by PCR (Expand
Long Template PCR Kit, Boehringer Mannheim) using
expression vector pGGH31 as a template. The primers used
for the PCR were 5 -AGTCTAATATCTAGACATGATG-
GCAAACTG-3  corresponding to the 5  end of the cDNA
(the initiation codon of the cDNA is underlined) and 5 -
TAAGGTTCCTTCGAAAAGATCGTC-3  corresponding to
the nucleotides next to the 3 -end of proα2(V) cDNA
in the pGGH31. The PCR products were cloned in to
pGEM-T easy-vector (Promega). The resulting pGEMTe-
5A2 was digested with XbaI-NotIa n dp r o α2(V) cDNA
was ligated to pVL1393 vector digested with XbaI-NotI
(pVLC5A2).
2.1.2. Yeast Constructs (Table 1). The proα1(V) cDNA
was ampliﬁed by PCR using the forward primer 5 -
AAGGTACCGCTCAGCCAGCAGATCTCC-3  and the
reverse primer 5 -AAGGTACCCTACGCGTAGTCCAC-
GTAGTTCTC-3  and pBS51nae as a template. A cDNA
fragment was obtained without the native signal sequence
and without the 3  area coding for the C-propeptide, but
including the C-telopeptide. Both primers contained a KpnI
restriction site (underlined) for cloning the cDNA fragment
into pPICZaA in frame with the Saccharomyces cerevisiae
α-factor secretion signal (αMF). The vector pPICZaA and
thePCRproductweredigestedwithKpnIandligatedandthe
resulting expression construct pPICZa-C5A1N was veriﬁed
with sequencing. For the yeast expression of the full length
collagen α1(V) chain the pGEMTe-C5A1 was digested with
NotI and the proα1(V) cDNA was ligated to pPIC3.5K yeast
vector (Invitrogen) digested with NotI (pPIC35-C5A1). To
allow plasmid linearization with SalIr e s t r i c t i o ne n z y m e
removal of a SalI site located in the exon 63 of proα1(V)
cDNA was performed by site directed mutagenesis. A
2.7kb fragment of pPIC35-C5A1 including the RrsII site
in the exon 55 of proα1(V) cDNA and the HpaIs i t ei n
the pPIC3.5-K vector was ampliﬁed and ligated to pGEMT
easy-vector. The resulting plasmid was used as a template for
introducing a null mutation according to the instructions of
the QuikChange kit (Stratagene). After the point mutation
was veriﬁed the plasmid was digested with RrsII-HpaIa n d
the insert was ligated to pPIC35-C5A1 digested with the
same enzymes (pPIC3.5K-C5A1M). To obtain the yeast
expression construct for full length collagen α2(V) chain
the pGEMTe-C5A2 was digested with SacII-NotI and ligated
to pPICZ-A vector (Invitrogen) digested with SacII-NotI
(pPICZ-C5A2).
2.1.3. Mammalian Expression Constructs. pcDNA3, pZeo-
SV2, and Rc-CMV (Invitrogen) were used to optimize the
stable production of both α1(V) and α2(V) collagen chains.
For mammalian episomal and transient expression, two
other vectors were used: pCEP4 and pCEP2 (Invitrogen).
These vectors expressed diﬀerent antibiotic resistance genes:
hygromycin for pcDNA3-Hygro and pCEP4, puromycin for
pCEP2, zeocin for pZeo-SV2, and neomycin for Rc-CMV.
The full-length cDNA of the proα1(V) chain was excised
from the Bluescript vector KS (as previously described
in [19]) using KpnI and subcloned into the eukaryotic
expression vectors pcDNA3-Hygro and pZeo-SV2, and
into the mammalian episomal expression vectors pCEP4
and pCEP2. The full-length cDNA of proα2(V) chain
was digested with NotI, from the Bluescript vector KS,
and subcloned into the eukaryotic expression vector Rc-
CMV, and into the mammalian episomal expression vector
pCEP4. The cDNA of HSP47 was obtained from the cln9-
33 plasmid (kindly provided by Dr T. Homma, Kyoto,
Japan), after a HindIII/BamHI digestion and subcloned into
the mammalian episomal expression vectors pCEP4 and
pCEP2.
2.2. Cell Culture, Protein Production and Characterization
2.2.1. Generation of Recombinant α1(V) and α2(V) Bac-
uloviruses and Protein Production in Insect Cells. The plas-
midspVLC5A1andpVLC5A2wereseparatelyco-transfected
with modiﬁed Autographa californica nuclear polyhedrosis
virus DNA into Spodoptera frugiperda (Sf9) insect cells using
theBaculoGoldtransfectionkit(PharMingen).Theresultant
viral pools were collected, ampliﬁed, and puriﬁed using the
Baculovirus expression system (BD Biosciences). Trichoplu-
sia ni High Five (H5) insect cells were cultured in suspension
in SF-900 SFM medium (Invitrogen) and were infected with
baculoviruses coding for α1(V), α2(V) and a virus for both
α and β subunit of human prolyl-4-hydroxylase at relative
multiplicities of 3:1:1, respectively. Ascorbate was added
to the culture medium daily at 80μg/ml. The cells and
culture medium were collected 72h after infection and kept
at −20
◦C until used.
2.2.2. Production of Recombinant Collagen V in Pichia
Pastoris. The plasmids were linearized with SalI (pPIC3.5K-
C5A1M) and PmeI (pPICZa-C5A1N, pPICZ-C5A2) and
transformed either to a wild type P. pastoris X-33 or a
yJC300 strain expressing α-a n dβ-subunits of human prolyl-
4-hydroxylase [21] by electroporation according to vector
manufacturer’s instructions (Invitrogen). Cells positive for
genomic PCR for collagen V sequences were grown in a
buﬀered glycerol complex medium (BMGY, pH 6.0) in 25ml
shaker ﬂasks. Expression was induced in a buﬀered minimal
methanol medium (BMM, pH 6.0) and methanol was added
to a ﬁnal concentration of 0.5% daily. Histidine was added to
negative control up to 100μg/l in the case of yJC300 strain.
Cells were harvested after 75h of methanol induction at
30
◦C, washed once with sterile H2O and divided into 100 mg
aliquots and kept at −20
◦C until used.4 Journal of Biomedicine and Biotechnology
2.2.3. Protein Production in Mammalian Cells. The human
embryonic kidney cell line, HEK-293 that constitutively
expresses the EBNA-1 protein from the Epstein-Barr virus,
allowing the episomal replication of the expression vectors;
the Chinese hamster ovary cell line, CHO-K1; the human
rhabdomyosarcoma cell line, A204; the human ﬁbrosarcoma
cell line, HT1080; the human carcinoma cell line, HeLa
and human dermal ﬁbroblasts were all cultured at 37
◦C
in DMEM (Dulbecco’s Modiﬁed Eagle’s Medium, Sigma),
supplemented with 10% foetal calf serum (Sigma), 50μg/ml
gentamicin (Sigma) in 5% CO2. Media were changed
every two days. The cells were transfected with expression
plasmids,usingthecalcium-phosphateprecipitationmethod
(Invitrogen) or the FuGene 6 transfection reagent (Roche),
accordingtothemanufacturer’sinstructions.Thetransfected
cells were selected during 15 days using hygromycin (250
or 300μg/ml), puromycin (0.5μg/ml), zeocin (1μg/ml),
neomycin (5μg/ml) or, for co-transfected plasmids, using a
mix of two diﬀerent antibiotics according to the expression
vector used. After selection, the resistant cells were cloned
and tested for protein expression. For further protein
production and characterization, cells were grown in serum-
free medium in the presence or absence of sodium ascorbate
(50μg/ml).
2.3. SDS-PAGE and Western-Blot Analyses. Recombinant
expression of the proα1(V) and proα2(V) chains in insect
cells was analyzed as follows: the cells were homogenized
with a glass homogenizer in 0.2M NaCl, 0.1% Triton X-
100, and 0.05M Tris buﬀer, pH 7.4, and centrifuged at
10,000g for 10min. The media and the soluble fractions
of the cells were analyzed by denaturing 4–6% SDS-PAGE
under reducing conditions followed by Coomassie blue or
staining and Western blotting with a monoclonal antibody
95D1A [15].
For recombinant protein expression analysis, the yeast
cells were homogenized by vortexing with glass beads in
neutral buﬀer (0.267M NaCl, 60mM Tris-HCl, pH 7.4,
0.2% Triton X-100), acidic (0.1M HCl), or basic (50mM
NaOH) solutions. The lysate was centrifuged at 10000×g
for 15min and aliquots of soluble fractions were analyzed by
denaturing SDS-PAGE under reducing conditions followed
byelectrotransferontopolyvinylidenediﬂuoridemembranes
(Immobilon-P, Millipore) overnight in 10mM CAPS (pH
11), 5% methanol. After saturation, membranes were then
incubated with monoclonal antibody 95D1A [15]a n da
monoclonal antibody 18G5 [22]. The peroxidase conjugated
secondary antibodies for the Western blots of the insect cell
and yeast expression products were detected with an ECL
Western Blotting Analysis System (Amersham Biosciences).
Relative band intensities were determined after scanning
the original membranes (or the dried gel) on optimized,
nonedited images, using Quantity One image analysis soft-
ware (version 4.6.5), after background substraction.
Recombinant protein expression (proα1(V), proα2(V)
and HSP47) in mammalian cells was checked by 6% or
12% (SDS-PAGE) analysis of HEK-293 resistant cells media
and lysates, followed by Coomassie Blue staining or by
electrotransfer and immunostaining. In some cases, cell
layerswerescrapedintophosphate-buﬀeredsaline(PBS)and
centrifuged5minutesat400g.Thepelletwasresuspendedin
lysatebuﬀer(100mMNaCl,20mMTris-HClpH7.6,25mM
EDTA, 5mM N-ethylmaleimide, 2mM phenylmethanesul-
f o n y lﬂ u o r i d e ,0 . 1 %S D S ,1 %N o n i d e tP - 4 0 ) .C e l ll y s a t e s
were centrifuged, and supernatants were analyzed by SDS-
PAGE followed by Coomassie Blue staining or by Western
blotting. The Western blot membranes of mammalian cell
expressionproductswereincubatedwithdiﬀerentantibodies
as indicated: the monoclonal 18G5 antibody against the
recombinant N-propeptide of the proα1(V) chain [22], the
polyclonal collagen type V (G-15) antibody against the N-
propeptide of the proα2(V) chain (Santa Cruz Biotechnol-
ogy,Inc.California),polyclonalantibodiesagainstthehelical
domain of the α1(V), α2(V) and α3(V) chains (Novotec,
France), and the monoclonal anti-HSP47 (colligin) antibody
(Stressgen Victoria, BC, Canada). Alkaline phosphatase
conjugated secondary antibodies were detected with an AP
Color kit (BioRad), and peroxydase conjugated secondary
antibodies with a Fast 3-3  DiAminoBenzidine Tablet Sets
(Sigma) or with an ECL Western Blotting Analysis System
(Amersham, Biosciences).
2.4. Protein Puriﬁcation for Mammalian Cell Expression
Products. For puriﬁcation of a large amount of proteins,
transfected cells were selected with antibiotics during 15
days, rinsed three times with PBS and placed in serum-free
medium. Then, this medium was collected every 48h and
stored at −20
◦C. For separation of the diﬀerent collagen
molecular species when cells were transfected with proα1(V)
and proα2(V) chains, media were dialyzed against 50mM
Tris-HCl pH 8.6 to precipitate the collagen V homotrimer
as in [19]. After centrifugation, the pellet containing the
homotrimer was resuspended in 50mM Tris-HCl pH 7.5,
150mM NaCl. The supernatant was passed over a DEAE-
cellulose column (DE-52, Whatman) and subsequently
eluted with a linear 0–0.6M NaCl gradient. The diﬀerent
fractions obtained were analyzed by Western blotting.
For puriﬁcation of the proα2(V) chains, transfected cell
media were dialyzed against 50mM Tris-HCl pH 8.6 and
passed over a DEAE-cellulose column (DE-52, Whatman)
and eluted with a linear gradient 0–0.6M. The eluant was
then dialyzed against 40mM sodium acetate buﬀer pH 4.8.
After centrifugation, the supernatant was passed over a
HiTrap-SP column (Pharmacia-Biotech) and subsequently
eluted with a linear 0–0.6M NaCl gradient. The diﬀerent
f r a c t i o n sw e r ea n a l y z e db y6 %S D S - P A G E .T h ep r o α2(V)
containing fractions were pooled and stored at −80
◦C.
2.5. Proteolytic Digestion and Monensin Treatment. Yeast and
insect cell expression products were digested with pepsin
to attest for the triple helix formation. The pH of the
sample was adjusted to around 2 with 2M HCl and pepsin
was added to a ﬁnal concentration of 200–250μg/ml. The
reaction solution was incubated at room temperature for 1h,
neutralizedwith2MNaOHandanaliquotofthesamplewas
analyzed by SDS-PAGE under reducing conditions followedJournal of Biomedicine and Biotechnology 5
Table 1: Yeast expression constructs, host cells, and recombinant
strains.
Constructs Host cells Recombinant yeast strains
pPICZα-C5A1N P. pastoris
X-33
α1(V) chain with αMF signal,
without C-propeptide
pPIC3.5K-C5A1M P. pastoris
yJC300 full length prepro-α1(V) chain
pPICZ-C5A2 P. pastoris
yJC300 full length prepro-α2(V) chain
by Coomassie blue staining and Western blotting with
monoclonal antibody 95D1A.
For mammalian cell media, the diﬀerent samples were
digested with pepsin (Sigma) in 0.5M acetic acid for 3h
at 20
◦C with an enzyme/substrate ratio of approximately
1:5. When indicated, 4·105 HEK-293 cells (C2 clone) were
plated in 35mm diameter Petri dishes and treated the day
after with 50μM monensin. After two hours incubation,
cells were rinsed twice with PBS and incubated in culture
medium for 24 h. Media were then collected and treated
with pepsin in 0.5M acetic acid for 2h at 20
◦Cw i t ha n
enzyme/substrate ratio of 1:10. Samples were analyzed by
Westernblottingusingpolyclonalantibodiesagainstcollagen
V α-chains. For bacterial collagenase digestions, serum-free
medium was puriﬁed as described above. The sample was
diluted in an optimal buﬀer: 25mM Tris-HCl pH 7.5, 0.5M
NaCl, 6mM CaCl2. Collagenase digestion was performed
at 37
◦C for 3h with an enzyme/substrate ratio of 1:7
(Advanced Biofacture).
The puriﬁed proα2(V) chain digestion by BMP-1 was
performed essentially as previously described [23]. Brieﬂy,
the puriﬁed proα2(V) chain (100ng) was incubated with
BMP-1 (6ng) in 25μl of 50mM Tris-HCl, 150mM NaCl,
5mM CaCl 2,p H7 . 5 ,f o r6 ha t3 7
◦C. The reaction was
stopped by heating at 60
◦C for 15 minutes in Laemmli SDS
sample buﬀer containing 4% 2-mercaptoethanol. Digestion
products were analyzed by 12% SDS-PAGE followed by silver
staining.
2.6. Analytical Methods. For N-terminal sequencing of the
proα2(V) chain, proteins were transferred to a polyvinyli-
dene diﬂuoride membrane and treated with pyrogluta-
mate aminopeptidase (Boehringer-Mannheim) to remove
the pyroglutamic acid blocking groups before performing
automated Edman degradation. Amino acid sequencing
was performed by automated Edman degradation using an
Applied Biosystems 473A protein sequencer.
Amino acid compositions were determined after hydrol-
ysis under vacuum (6N HCl, 115
◦C, 24h) in the presence
of 2-mercaptoethanol in a Pico Tag system (Waters) with a
Beckman amino acid analyzer.
2.7. Immunoﬂuorescence. Human dermal ﬁbroblasts, HeLa
cells which have been transiently transfected with α1(V)
and α2(V), and clone C2 (stably transfected with proα1(V),
proα2(V) and HSP47 constructs as described above) were
used for immunoﬂuorescence double staining with the
monoclonal antibody against collagen V proα1-chain (18G5
[22]) and the rabbit polyclonal antibodies raised against a
synthetic peptide derived from the N-terminus of the proα2-
chain (a generous gift from D.E. Birk, University of South
Florida, USA).
For HeLa cell transient transfection, 2·105 cells were
plated in 60mm diameter Petri dishes and co-transfected the
following day with the proα1(V) and proα2(V) expression
plasmids,usingthecalcium-phosphateprecipitationmethod
accordingtothemanufacturer’sinstructions(Invitrogen).48
h after transfection, cells were washed three times with PBS
andﬁxedfor20minwith4%paraformaldehydeinPBS.After
three washes with PBS, cells were permeabilized with 0.1%
Triton in PBS and then blocked with 1% BSA. Eﬃciency
of transfection was analyzed by transfecting the cells with
a plasmid that expresses green ﬂuorescent protein (GFP) as
previously described [22]. The percentage of transfection
was calculated 48 h after transfection by counting green
cellswithaninversedmicroscopeequippedwithﬂuorescence
(Nikon). The values varied from 50% to 70% depending on
the experiments.
For immunoﬂuorescence, cells were grown for 24h in
medium supplemented with 50μg/ml sodium ascorbate.
After washing with PBS, cells were ﬁxed for 20min with 4%
paraformaldehyde. After three washes with PBS, cells were
permeabilized with Triton 0.1% in PBS and blocked with
BSA 1% in PBS. Cells were ﬁrst incubated for 1 hour with
the monoclonal antibody 18G5 followed by incubation with
secondary antibodies conjugated with Alexa 546 for 30min.
Then,cellswereincubatedwithpolyclonalantibodiesagainst
the proα2(V) chain followed by incubation with secondary
antibodies conjugated with Alexa 488. As negative con-
trols, primary antibodies were replaced by PBS. Coverslips
were mounted in Dakocytomation Fluorescent Mounting
Medium (Dako) and observed with a Zeiss Axioplan2
ﬂuorescence microscope equipped with a high-resolution
digital camera.
3. Results
3.1. Expression of Recombinant Human Collagen V Het-
erotrimer in Insect Cells. In order to obtain recombi-
nant human collagen V heterotrimers in insect cells by
baculovirus expression system, recombinant baculoviruses
coding for proα1(V) and proα2(V) chains were generated
and used to infect High Five insect cells together with a
virus coding for both subunits of prolyl 4-hydroxylase. No
collagen band was detectable in cell lysates and media of
infected cells with Coomassie blue staining and Western
blot analysis revealed that both collagen chains were faintly
expressed in addition to protein degradation products
(data not shown). A negligible amount of the collagen V
molecules (heterotrimer and homotrimer) is produced in
the baculovirus-insect cell expression system, indicating that
the housekeeping and secretion machinery of insect cells
are not adapted to the recombinant collagen V molecule
production.6 Journal of Biomedicine and Biotechnology
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Figure 1: Expression of α1(V) without the native signal sequence and the C-propeptide (a, b) and of α1(V)/α2(V) chains (c) in P. pastoris.
(a) 5% SDS-PAGE analysis under reducing conditions of the soluble fraction of acidic extraction from untransformed yeast cells (lane 1)
and from yeast cells transformed with the construct pPICZα-C5A1N (lane 2). (b) Western blot analysis of the same samples as in panel (a)
probed with monoclonal pan-collagen antibody 95D1A. (c) Western blot analysis of the soluble fraction of neutral extraction of yeast cells
transformed with α1(V) and α2(V) chains and induced with 0.5% methanol induction. Samples were incubated without (lane 1) or with
(lane 2) pepsin before analysis. Left, molecular mass standards expressed in kDa.
3.2. Expression of Recombinant Human Collagen V Het-
erotrimer in Yeast. The yeast P. pastoris, was selected based
on previous data obtained on recombinant expression of
the ﬁbrillar collagens I, II, and III in P. pastoris [12–14].
Moreover, it has been shown that collagen I can eﬃciently
be expressed in yeast as a heterotrimer [11].
Several expression constructs for producing human
collagen V in P. pastoris were generated. The ﬁrst expression
construct encoding the proα1(V) chain without the C-
propeptide and the native signal sequence replaced with
the S. cerevisiae α-factor secretion signal (pPICZa-C5A1N,
Table 1) was transformed by electroporation into a wild type
P. pastoris strain X-33. The positive strain was cultured in
buﬀered glycerol complex medium and the expression was
induced in buﬀered minimal methanol medium. Medium
and aliquots of soluble fraction of acidic extraction of the
yeast cells were analyzed by SDS-PAGE under reducing
conditions followed by Coomassie blue staining or Western
blotting with the monoclonal antibody 18G5 to the collagen
V α1 N-propeptide and with the monoclonal antibody
95D1A.Nohighmolecularweightbandwasdetectableeither
with Coomassie blue staining or Western blotting in the
mediumsuggesting thatthe proα1(V)chain wasnot secreted
despite the presence of S. cerevisiae α-factor secretion signal
in the N-terminus of the proα1(V) chain. After Coomassie
blue staining a faint band with high-molecular weight was
detected in the cell sample (Figure 1(a), lane 2) that is absent
in untransformed cells (Figure 1(a), lane 1). Nevertheless,
this indicates that a higher expression level can be obtained
inyeastwhencomparedtoinsectcellsforwhichnobandwas
readily detectable in Coomassie blue stained gels.
Lysates of cells transfected with the construct containing
the proα1(V) chain devoid of the native signal sequence
and the C-propeptide were analyzed by Western blotting
using both 95D1A (Figure 1(b), lane 2) and 18G5 anti-
bodies (data not shown). Both antibodies recognized high
molecular weight bands, corresponding to the pNα1(V)
chain which is absent in untransformed cells (Figure 1(b),
lane 1). Surprisingly, the proα1 ( V )c h a i ne x p r e s s e dw i t h
native signal sequence and C-propeptide had unexpectedly
low abundance detectable only by Western blotting (data
not shown). To further obtain recombinant collagen V
molecules from association of the intact pro-chain cDNAs,
the yeast constructs coding for prepro-α1(V) and prepro-
α2(V) chains (pPIC3.5K-C5A1M and pPICZ-C5A2, Table 1)
were transformed by electroporation into P. pastoris yJC300
strain expressing active human prolyl 4-hydroxylase. The
strains were cultured and the protein production was
induced as above. Two high-molecular weight bands were
detected by western blot probed with 95D1A in the neutral
extract (Figure 1(c), lane 1). The recombinant collagen V
yield in yeast is mostly underestimated since a large amount
of recombinant protein remains in the insoluble material
(data not shown). After pepsin treatment, two bands were
detected with the correct position of the pepsinized α1
and α2 chains of the native collagen V heterotrimer indi-
cating that the heterotrimer is correctly formed in yeast
(Figure 1(c), lane 2). However, the α1/α2c h a i nr a t i o( 4 : 1
as estimated by gel densitometry) indicated that a mixture
of collagen V homotrimer and heterotrimer molecules are
produced.
3.3. Production and Characterization of the Proα2(V) Chain
in Mammalian Cells. Prior to expressing the collagen V
heterotrimer, the production and characterization of the
human proα2(V) chains in HEK-293 cells singly transfectedJournal of Biomedicine and Biotechnology 7
with the mammalian episomal expression vector pCEP4-
α2(V) were analyzed by biochemical approaches. Elec-
trophoresis analysis of serum-free medium from proα2(V)-
transfectedcellsdemonstratedanadditional 200kDaprotein
band, which was absent in non-transfected cells medium
(Figure 2(a)). Moreover, this protein band corresponded to
the expected molecular mass for the full proα2(V) chain. N-
terminal amino-acid sequencing conﬁrmed that this band
is the proα2(V) chain. The N-terminal sequence obtained
after pyroglutamate aminopeptidase treatment, Glu-Glu-
Asp-Glu-Asp-Glu-Gly, identiﬁed this band as the human
proα2(V) chain and indicated that the peptide bond Ala26-
Glu27 is the signal peptide cleavage site. In nonreduced
conditions, the proα2(V) chain migrated only slightly faster
than the proα2(V) chain in reduced conditions likely due
to the presence of intrachain disulﬁde bonds within the N-
terminal noncollagenous cystein rich domain. The secretion
in the medium of the proα2(V) chains was unexpected
for two reasons. First, the proα2(V) chains were shown to
be unable to form homotrimers [24, 25]. In tissues, the
proα2(V) chains form a heterotrimer with two proα1(V)
chains. Second, it is acknowledged that ﬁbrillar collagens
that are not properly folded are degraded intracellularly. To
check whether in our experimental conditions, the proα2(V)
chains can fold into a triple helix, proα2(V)-transfected cell
medium was digested with pepsin. The results showed that
the 200kDa protein band disappeared after pepsin treatment
(Figure 2(a)), indicating that the proα2(V) chains did not
fold into a stable triple helix but can be secreted. The
best yield obtained for the recombinant proα2(V) chain
production was 15μg/ml.
The presence of the N- and C-propeptides was veriﬁed
by bacterial collagenase treatment of medium from α2(V)-
transfected cells (Figure 2(b)). The 200kDa protein band,
which corresponded to the full proα2(V), disappeared in
the presence of collagenase and two bands with lower
molecular weights were observed. The lower protein band
corresponded to the N-terminal cystein rich domain. In
reduced conditions, this band migrated slightly slower
compared to the nonreduced conditions (Figure 2(b)). In
reduced conditions, the protein band observed at 33kDa
corresponded to the C-propeptide. In unreduced conditions,
the protein migrated slower likely due to intrachain disulﬁde
bonds. This result showed that interchain disulﬁde bonds
did not form as was the case for the proα1(V) chains
produced in the same cell system [19]. It also conﬁrmed
that the proα2(V) chains did not form a triple helix. The C-
propeptide of the proα2(V) chains when incorporated into
a heterotrimer was shown to be processed by BMP-1 [26].
Digestion of puriﬁed recombinant proα2(V) chains with
BMP-1 showed the presence of a band corresponding to the
C-propeptide(Figure 2(c)).Thisresultisnotsurprisingsince
BMP-1 activity is not dependent on triple helix formation.
These results all together indicate that the proα2(V) chains
can be eﬃciently produced in HEK-293 cells and that the
recombinant chains exhibited the same features as the native
chains.
To optimize the proα1(V) and the proα2(V) chains
production in HEK-293 cells in order to favor heterotrimer
formation, diﬀerent constructs were prepared and diﬀerent
clones were selected after cotransfection with the diﬀerent
constructs for their high expression of the two pro-chains.
The cDNA of the proα1(V) chain was cloned in two
eukaryoticexpressionvectors,pZeo-SV2andpcDNA-Hygro,
containing the SV40 and the CMV promoters, respectively.
The cDNA of the proα2(V) chain was cloned in the Rc-
CMV eukaryotic expression vector containing the CMV
promoter. The construct α2(V)-Rc-CMV was co-transfected
with either α1(V)-pZeo-SV2 or α1(V)-pcDNA-Hygro, in
HEK-293 cells. After selection with the appropriate antibi-
otics,theserum-freeculturemediawereanalyzedbyWestern
blotting with antibodies to collagen V (Figure 3). In order
to modulate the expression ratio between proα1(V) and
proα2(V) chains, three clones were selected: (i) clone F22
which expressed more eﬃciently the proα1(V) chain than
the proα2(V) chain; (ii) clone C22 which expressed higher
levels of proα2(V) chain than proα1(V) chain and (iii) clone
C32 which equally expressed the two chains (Figure 3). The
results suggested that the CMV promoter is more eﬃcient
for the ﬁbrillar collagen chain expression than the SV40
promoter.
TheanalysisoftherecombinantprocollagenVmolecular
forms from the three selected clones C22, C32, and F22
gave similar results. As a representative example, the results
presented here were obtained with the clone C22, in which
expression level of the proα2(V) chain was higher than
the proα1(V) chain (Figure 4). The transfected cell medium
was dialyzed against Tris-HCl 50mM pH 8.6 to eliminate
most of the formed homotrimer (data not shown) [19].
After centrifugation, a fraction of the supernatant which
contained both proα1(V) and proα2(V) chains was digested
with pepsin prior to Western blot analysis (Figure 4(a)).
After digestion with pepsin, the protein bands migrated
at the pepsinised α1(V) and α2(V) chain positions. The
intensity of the proα1(V) band was identical before and
after pepsin digestion, contrary to the intensity of the
proα2(V) band, which was weaker after pepsin digestion
(Figure 4(a)). This result indicated that a large fraction of
the proα2(V) chains did not fold into a heterotrimer and
were produced as free pro-chains. To separate the diﬀerent
collagen V molecular species, the supernatant was applied to
acationexchangechromatography.Theelutedfractionswere
analyzed to detect both pro-chains by Western blotting using
two diﬀerent collagen V antibodies and detection systems as
described in Section 2 to discriminate the α1(V) and α2(V)
chains (Figure 4(b)). Three populations of molecular forms
wereidentiﬁed. Thefreeproα2(V)chaincontainingfraction,
was ﬁrst eluted at 0.16M NaCl. Then, another peak eluted at
0.24M was shown to contain proα1(V) and proα2(V) chains
with an estimated ratio of 2:1 and likely corresponded
to the heterotrimer. Finally, fractions eluted at 0.37M and
0.42M NaCl were shown to contain only the proα1(V)
chains and could correspond to the homotrimer. Thus, only
as m a l la m o u n to fp r o α2(V) chains were found associated
to the proα1(V) chains to form the heterotrimer. Contrary
to the in vivo situation, the heterotrimer was not the major
molecular form produced by the HEK-293 mammalian
cells.8 Journal of Biomedicine and Biotechnology
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Figure 2: Biochemical analysis of the recombinant proα2(V) chains produced in HEK-293 cells. (a) 6% SDS-PAGE analysis of cell media
from untransfected cells (lane 1) and from cells transfected with human proα2(V) construct (lanes 2–5) under unreduced (lanes 1, 2) or
reduced(lanes3,4,5)conditions.Transfectedcellsmediawereincubatedwithout(lane4)orwith(lane5)pepsinbeforeSDS-PAGEanalysis.
(b) Digestion with bacterial collagenase: transfected cell media were incubated without (lane 1) or with (lanes 2, 3) collagenase before 12%
SDS-PAGE analysis under reduced (lanes 1, 2) or unreduced (lane 3) conditions. (c) Digestion with BMP-1: 12% SDS-PAGE patterns of
transfected cells media digested (lane 2) or not (lane 1) with BMP-1. Gels (a) and (b) were stained with Coomassie blue whereas gel (c) was
silver stained. Left, molecular mass standards expressed in kDa. NT: not transfected, proα2(V): transfected with proα2(V) construct, DTT:
dithiothreitol, Cpro:C - p r o p e p t i d e ,Npro:N - p r o p e p t i d e ,BMP-1: Bone Morphogenetic Protein 1.
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Figure 3: Selection of clones expressing α1(V) and α2(V) chains.
Western blot analysis with antibody to collagen V of recombinant
α1(V) and α2(V) chains synthesized and secreted in the culture
medium of co-transfected HEK-293 cells. The constructs α1(V)-
pZeo-SV2 (lanes 2, 3) or α1(V)-pcDNA-Hygro (lane 4) and the
construct α2(V)-Rc-CMV (lanes 2, 3, 4) were co-transfected into
the HEK-293 cells. These cells do not naturally express these chains
(lane 1). Three clones have been selected to express diﬀerent ratios
of α1(V)/α2(V): clone C22, which expressed more of the α2(V)
chainthantheα1(V)chain,cloneC32,whichexpressedbothchains
at approximately the same amount, and clone F22, which expressed
more of the α1(V)chain than the α2(V)chain. Left, molecular mass
standards expressed in kDa.
3.4. Eﬀect of HSP47, a Collagen-Speciﬁc Chaperone Protein,
in Collagen V Heterotrimer Expression in HEK-293 Cells. The
HEK-293 cells were shown to contain the cell machinery
necessaryforcorrectbiosynthesisofprocollagens[19,27].To
understand the failure to favor heterotrimer [α1(V)]2α2(V)
in these cells, we hypothesize that one of the enzyme or/and
chaperone proteins crucial for chain assembly may lack. The
heat shock protein HSP47, described as a collagen-speciﬁc
molecular chaperone, was a potential good candidate. The
level of HSP47 expression was undetectable in the HEK-
293 cell lysates (Figure 5(a)). In contrast, the presence of
HSP47 was detected in several other cells lines (Figure 5(a))
such as HT1080, HeLa, A204, and CHO-K1 cells for which
endogenous collagen V expression was shown by Western
blotting (data not shown). Cell lysates were all positive for
HSP47 expression except the HEK-293 cells. This result
suggested that HSP47 could be necessary for the eﬃcient
heterotrimer [α1(V)]2α2(V) production.
Two constructs, pCEP4-Hsp47 and pCEP2-Hsp47, were
prepared. HEK-293 cells were then transiently transfected
and the cells lysates were analyzed by Western blotting
(Figure 5(b)). The HeLa cell line was used as a positive
control. Contrary to untransfected cells, in the HEK-293
cells transfected with the pCEP4-Hsp47 or pCEP2-Hsp47
construct, two bands were detected by immunodetection
with antibodies to HSP47. The upper protein band migrated
at the expected position and likely corresponds to the mature
form of HSP47. The faster band probably corresponds to the
unglycosylated form of HSP47 as described in [28].
The HEK-293 cells were then transfected with three
diﬀerent constructs: pCEP4-α2(V) and pCEP4-α1(V) or
pCEP2-α1(V) together with pCEP4-Hsp47 or pCEP2-
Hsp47. Diﬀerent transfection combinations were tested: (1)
pCEP4-α1(V), pCEP4-α2(V) and pCEP4-HSP47, (2)
pCEP4-α1(V), pCEP4-α2(V) and pCEP2-Hsp47, (3)
pCEP2-α1(V), pCEP4-α2(V) and pCEP4-Hsp47, and
(4) pCEP2-α1(V), pCEP4-α2(V) and pCEP2-Hsp47.
Hygromycin or/and puromycin were used for positive
cell selection depending on the constructs used for cell
transfection. From all these tested combinations, we
failed to get substantial expression of the three partnersJournal of Biomedicine and Biotechnology 9
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Figure 4: Characterization of the recombinant procollagen V molecular forms produced in HEK-293 transfected cells. (a) Western blot
analysis of the supernatant of transfected cell media dialysed against Tris-HCl 50mM, pH 8.6, digested (lane 2) or not (lane1) with pepsin.
Transfected cell media were centrifuged and the supernatant was applied to a DEAE column. (b) Separation of the diﬀerent collagen V
molecular species from transfected cell media by cation exchange chromatography. Western blot analysis of the loaded sample (lane 1) and
of the fractions eluted at 0.16M (lane 2), 0.24M (lane 3), 0.37M (lane 4), and 0.42M (lane 5) NaCl. Membranes were double probed
with mAb 18G5 followed by alkaline phosphatase antimouse secondary antibodies and with pAb CollV followed by peroxydase antirabbit
secondary antibodies. Left, molecular mass standards expressed in kDa.
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Figure 5: (a) HSP47 expression in diﬀerent cell lines. Western blot analysis of conditioned cell lysates from diﬀerent cell lines probed
with monoclonal antibody to HSP47. Left, molecular mass standards expressed in kDa. (b) Western blot analysis of HSP47 expression in
untransfected HEK-293 cells (lane 1), HEK-293 cells transfected with pCEP2-HSP47 (lane 2) or with pCEP4-HSP47 (lane 3) constructs and
in HeLa cell lysate as positive control (lane 4). Two bands were detected in transfected HEK-293 cells lysates corresponding, respectively, to
the glycosylated and unglycosylated forms. Left, molecular mass standards expressed in kDa.
together. Therefore, HEK-293 cells were transfected with the
pCEP2-α1(V), pCEP4-α2(V) and pCEP2-Hsp47 constructs,
stable clones were obtained and tested for the expression
of the three partners. Lysates and media of twenty-one
diﬀerent clones were analyzed by Western blotting. The
three partners, the recombinant proα1(V), proα2(V) chains
and HSP47 (Figure 6(a)), were expressed together in only
ﬁve clones named C2, C7, C9, C13, and C15. These clones
expressed the recombinant proα1(V) and proα2(V) chains
with diﬀerent ratios (Figure 6(a)). The clones C2 (lane1),
C13 (lane 4) and C15 (lane 5) expressed similarly the
recombinant proα1(V) and proα2(V). The proα1(V) chain
was expressed at a higher level than the proα2(V) chain
in clones C7 (lane 2) and C9 (lane 3). As an example,
the clone C12 (Figure 6(a), lane 6) only expressed the
proα1(V) chain and HSP47. Unfortunately, pepsin digestion
of culture media from the ﬁve selected clones revealed
that even in the presence of HSP47, the homotrimer was
again the major molecular form produced by the cells.
As illustrated for clone C2 (Figure 6(b)), Western blot
analysis of conditioned media treated with or without
pepsin revealed the presence of two major pepsin-resistant
bands migrating in the position expected for the α1(V)
and α2(V) chains, respectively. The ratio between the
α1(V) and the α2(V) bands showed that, expression of
HSP47 in HEK-293 cells did not increase the heterotrimer
production. The heterotrimer [α1(V)]2α2(V) production
by other mammalian cell lines, CHO and Hela cells, which
both endogenously produce low amounts of collagen V, was
analyzed after cotransfection of the 2 proα-chains of collagen
V. The analysis of the collected media did not show any
signiﬁcant increased of collagen V heterotrimer production
(data not shown). The next question was whether monensin
treatment, which blocks the vesicle transport within the10 Journal of Biomedicine and Biotechnology
(kDa) 1 2 4 35 6
200
200
66
45
C2 C7 C9 C13 C15 C12
HSP47
pNα1(V)
proα2(V)
(a)
( k D a ) 1234
200
150
− + − +
−− ++
Pepsin
Monensin
proα1(V)
pNα1(V)
proα2(V)
α1(V)
α2(V)
(b)
Figure 6: (a) Selection of clones expressing proα1(V), proα2(V)
chains and HSP47. Western blot analysis of transfected cell media
(for proα1(V) and proα2(V) chain detection) or cell lysates
(for HSP47 detection) probed with (ﬁrst panel) 6A7 monoclonal
antibody, which recognizes the N-propeptide of the human
proα1(V) chain, (second panel) with collagen type V (G-15)
antibodies, which recognize the human proα2(V) chain, (third
panel) with antibody to HSP47. Of twenty-one clones, only ﬁve
clones expressed the three partners with diﬀerent expression levels:
C2 (lane 1), C7 (lane 2), C9 (lane3), C13 (lane 4), and C15 (lane
5). The other clones expressed only two of the three partners. For
example, clone C12 (lane 6) expressed only the proα1(V) chain
and HSP47. (b) Western blot analysis of media from clone C2
treated with (lanes 3, 4) or without monensin (lanes 1, 2) using
polyclonal collagen V antibodies. Media were incubated with (lanes
2, 4) or without pepsin (lanes 1, 3). Left, molecular mass standards
expressed in kDa.
Golgi complex, can improve the procollagen V heterotrimer
production. We argue that the transient retention of the
newly synthesized proα-chains in the endoplasmic reticulum
(ER) can favor the procollagen V heterotrimer formation
and its subsequent secretion after monensin removing.
Conditioned media of clone C2 treated with monensin
for 2 h were collected and digested with pepsin before
Western blot analysis (Figure 6(b)). Surprisingly, only one
band was revealed by the polyclonal antibodies to collagen
V which migrated in the position of the proα1(V) chain.
This band is converted to a faster migrating product after
pepsin treatment which corresponded to the position of
the α1(V) triple helix domain (Figure 6(b)). The lack of
proα2(V) monomer secretion after monensin treatment
indicatesthattheretentionoftheproα2(V) intheERdidnot
improve hetrotrimer formation but caused its intracellular
degradation.
To determine the intracellularlocalization ofthe collagen
Vproα-chainsintransfectedmammaliancells,weperformed
immunoﬂuorescence staining using speciﬁc antibodies to
the proα1(V) and the proα2(V) chains in transfected HEK-
293 and HeLa cells compared to cultured human dermal
ﬁbroblasts which endogenously express collagen V het-
erotrimer.Fortheseexperiments,weusedthecloneC2which
stably express high levels of the proα1(V) and proα2(V)
chains and HSP47 (Figure 6(a)). The proα1(V) and the
proα2(V) chains were transiently expressed in HeLa cells
which endogenously express HSP47 (Figure 5(a)). In ﬁbrob-
lasts, the proα1(V) and proα2(V) chains mainly colocalized
in ER and secretory vacuoles (Figure 7). Surprisingly, the
proα1(V) and proα2(V) chains showed distinct intracellular
distribution in stably transfected HEK-293 cells and in
transiently transfected HeLa cells (Figure 7).
4. Discussion
Whereas the recombinant production of collagen homot-
r i m e r sh a sb e e na c h i e v e di nd i ﬀerent expression systems, the
production of collagen heterotrimers is still challenging. In a
previous study, we have shown that collagen V homotrimer
[α1(V)]3 can be produced in substantial amounts in HEK-
293 cells (about 20mg/L) [19]. In the present report,
the diﬀerent expression systems used so far to express
recombinant collagens have been tested in parallel for their
capacity to produce high amount of collagen V heterotrimer
[α1(V)]2α2(V) which is the most prevalent molecular form
encountered in tissues.
Here we show that insect cells infected with recombinant
baculovirus carrying full-length proα1(V) and proα2(V)
expressed both chains, but at very low levels, which were
undetectable with Coomassie blue staining. Moreover, cell
infection with both chains led to the prevalent formation of
the homotrimer [α1(V)]3 (data not shown). More intriguing
is the result we obtained with the yeast expression system.
Theyeastsystemhasbeendescribedasanidealsystemforthe
high-level production of various recombinant collagens for
numerous scientiﬁc and medical purposes. Yields in excess
of 1g/L have been achieved for collagen types I-III [12]. We
show that collagen V heterotrimer was eﬃciently produced
in the yeast system but in much lower level than the collagen
Ih e t e r o t r i m e r[ 12]. Whereas the procollagen α1(V) chain
was weakly expressed in P. pastoris transformed with α1(V)
chain alone, pepsin-resistant collagen V heterotrimer was
obtained in yeasts cotransformed by the two collagen V
α chains. However, the collagen V heterotrimer production
level is far from reaching the yields obtained for collagen I
heterotrimers.
Many studies have enlightened the critical role of endo-
plasmic reticulum-resident enzymes and molecular chaper-
ones in the collagen assembly pathway, from the folding and
assembly, to the quality control and secretion [29, 30]. The
roles of prolyl 4-hydroxylase and HSP47, a collagen-speciﬁcJournal of Biomedicine and Biotechnology 11
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Figure 7: Double immunoﬂuorescence staining was performed using monoclonal antibody against human proα1(V) chain (18G5) (a, d, g,
j) and rabbit polyclonal proα2(V) chain (b, e, h, m), and merge (c, f, i, l). (a, b, c) human dermal ﬁbroblasts; (d, e, f) clone 22 cells; (g)–
(l) HeLa cells transiently transfected with human proα1(V) and proα2(V) constructs. Double immunoﬂuorescence staining shows distinct
intracellular distribution of the proα(V) chains in round (g)–(i) and spreading (j, k, l) HeLa cells. Magniﬁcation: x1000.
binding protein, are the most documented. As discussed
above, yeast and insects cells show no or insuﬃcient P4H
activity and cotransfection with P4H subunits cDNA has
improved triple helical folding and stability [13]. Along the
line, mammalian cells appeared to be the most adapted
expression system to properly assemble collagen chains. The
HEK-293 cells are by far the most frequently used because
they proved to be eﬃcient for the production of numerous
recombinant extracellular matrix proteins. Several collagens,
a l lp r o d u c e da sh o m o t r i m e r s ,h a v eb e e ne ﬃciently expressed
in these cells [8]. Collagen V homotrimer was shown to
be fully hydroxylated indicating that HEK-293 cells express
endogenous P4H that is fully active [19]. However, in the
present study, only negligible amounts of heterotrimeric
collagen V were obtained by cotransfecting the proα1(V)
and proα2(V) chains and the proα1(V) homotrimeric
association was always prevalent, indicating that these cells
do not contain the full protein machinery necessary for
controlling collagen chain selection and assembly. Collagen
VIII was described as heterotrimers in tissues but has been
expressed as homotrimers in HEK-293 cells [31]. Also,
procollagen quality control and secretion appear to be
deﬁcient in HEK-293 cells. We show that pepsin-sensitive
proα2(V) monomers were secreted in substantial amounts
inHEK-293cellmedia.Fibrillarcollagenmoleculesassemble
through their C-propeptides that interact with each other
and form interchain disulﬁde bonds. In the absence of
reducing agent, the recombinant proα2(V) chain did not
migrate as a trimer though the presence of the C-propeptide
was attested. It migrated at the expected size (200kDa) and
after collagenase treatment, the digestion products migrated
at the position of the N- and C-propeptides. These results
show that the proα2(V) chains cannot assemble into trimers
as previously shown for the proα2(I) chains [16]. Most
importantly, our results showed that these cells lack quality
control proteins that can prevent collagen monomer secre-
tion. HSP47 is responsible for preventing aggregation and
secretion of partially folded and misfolded molecules rather
than for triple helix stabilization [32] and binds similarly
to collagens I to V in vitro [33]. Moreover, procollagens
secreted from Hsp47−/− mouse cells did not form correctly
aligned triple helices [34]. In earlier studies, mouse Hsp47
cDNA was introduced into insect cells to improve collagen I
heterotrimersecretion [35]. CotransfectionofHEK-293 cells
with HSP47 and proα1(III) constructs prevents for collagen
III overmodiﬁcation [36]. HSP47 may thus play critical role
in collagen V biosynthesis. Our results reveal that there is
a good correlation between the cell line capacity to express
endogenous collagen heterotrimers and HSP47. The A204
cells [37] and as we show in the present report, the CHO-
K1 and HeLa cells express low levels of endogenous collagen
V heterotrimer whereas the HT1080 cells express collagen IV
heterotrimer [38]. The CHO-K1 cells were used to produce
recombinant collagen IV heterotrimer [α1(IV)]2α2(IV),
though only negligible amounts were obtained [39]. We
show that they all express HSP47. Conversely, HSP47 and
collagenswereexpressedatanundetectablelevelintheHEK-
293 cells. In order to test whether HSP47 can favor collagen
V heterotrimer expression in HEK-293 cells, we have stably
transfectedcellswithhumanproα1(V),proα2(V)chainsand
HSP47 constructs. However, after a triple cell transfection
with Hsp47 and both collagen V proα-chains cDNAs, none
of the selected clones expressed collagen V heterotrimer
as the major molecular form. The results indicate that
neither P4H nor HSP47 are key factors controlling the
heterotrimer assembly of ﬁbrillar collagens. Uncontrolled
secretion of proα2(V) monomers by HEK-293 cells may be
unfavorable for heterotrimer formation. However, the use12 Journal of Biomedicine and Biotechnology
of monensin to retain the new synthesized α-chains in the
ER and subsequently improve heterotrimer folding had no
eﬀect on the level of collagen V heterotrimer expression.
The data even suggested that the retention of the proα2(V)
monomers in the ER increased its intracellular degradation
and limited its uncontrolled secretion as monomers. This
is in agreement with the role of the ER-resident HSP47 in
preventing aggregation and secretion of unfolded collagen
molecules [32].
Fibrillar collagens share similar structure and thus one
can expect that they share similar synthesis and folding
mechanisms. However, whatever the expression system
used, the preferred molecular form was the homotrimer
whereas ﬁbroblasts, the in vivo collagen-producing cells,
predominantly express collagen V heterotrimer. The HEK-
293 mammalian cells that likely contain the appropriate
environment to produce the collagen V heterotrimer, failed
to produce high amounts of collagen V heterotrimer whereas
they produce considerable amounts of the homotrimer [19].
TheHEK-293cellsareanepithelialcelllineoriginallyderived
from human embryonic kidney. Embryonic epithelial cells
can produce low amount of collagen V, the molecular
form they produced has not been characterized (for review
[19, 40]). It is possible that collagen V isoform assembly
is critically dependent upon the cell type. The lack of
coordinated and controlled synthesis of the two proα-chains
in transfected cells may also prevent heterotrimer formation.
Our double immunoﬂuorescence staining with antibodies
against the proα1(V) and proα2(V) chains showed that the
two proα-chains mainly colocalized in ﬁbroblasts whereas
they displayed distinct localization in transfected HEK-293
and HeLa cells. Another likely explanation is that collagen
V homotrimers may have intrinsic ability to form the triple
helical structure more easily than collagen V heterotrimer
and that the formation of the heterotrimeric molecular form
may require speciﬁc protein chaperones. HSP47 is not the
only molecule that has this function. SPARC family proteins
may have a similar chaperone activity. Collagens I and V
are generally coexpressed in tissues and produced by the
same cells, ﬁbroblasts and osteoblasts. Our results strongly
suggest that collagen V biosynthesis presents type-speciﬁc
pathway that at least partially diﬀers from collagen I. The
expression systems described here provide valuable model
systems to study key factors in collagen V heterotrimer chain
association.
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